{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4502"}, "official-title": {"#tail": "\n\t", "#text": "To authorize the Attorney General to exempt certain products from the requirements of subsections\n\t\t\t (d) and (e) of section 310 of the Controlled Substances Act if it is not\n\t\t\t practical to use such products in the illicit manufacture of\n\t\t\t methamphetamine."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140428", "#text": "April 28, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": " introduced the following bill; which was referred to the ", "#text": "Mr. Luetkemeyer", "@name-id": "L000569"}, "committee-name": [{"#tail": ", and in addition to the Committee on the ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such\n\t\t\t provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HJU00", "#text": "Judiciary"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H6913FAAA9CC0435497372D846C529DFA", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Stop Meth Labs and Enhance Patient Access Act of 2014", "@value": "Stop Meth Labs and Enhance Patient Access Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H316750D60CF64AC7AE8296B3CA0502B9"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t", "quote": [{"#tail": " and inserting ", "#text": "if the Attorney General determines that the product cannot be used in the illicit manufacture of\n\t\t\t methamphetamine"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines that it is not practical by processes known to be employed by\n\t\t\t clandestine laboratory operators to use the product in the illicit\n\t\t\t manufacture of methamphetamine", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, "#text": "if the "}], "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 310(e)(3) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:310/ss:e/p:3"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 830(e)(3)", "@value": "usc/21/830/e/3"}, "@parsable-cite": "usc/21/830", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Exemption if it is not practical to use product in illicit manufacture of methamphetamine"}, "#text": "\n      ", "@id": "H97313FEDFE9F4302BBD785789433CBF7"}], "#text": "\n\t\t", "@id": "H9DF1D16CEE5D42B79D4303C98E53F99F"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-04-28"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4502 IH: Stop Meth Labs and Enhance Patient Access Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}